- Home
- AKRO vs SKT Comparison
AKRO vs SKT Comparison
Compare AKRO & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- SKT
- Stock Information
- Founded
- AKRO 2017
- SKT 1981
- Country
- AKRO United States
- SKT United States
- Employees
- AKRO N/A
- SKT N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- SKT Real Estate Investment Trusts
- Sector
- AKRO Health Care
- SKT Real Estate
- Exchange
- AKRO Nasdaq
- SKT Nasdaq
- Market Cap
- AKRO 3.9B
- SKT 3.3B
- IPO Year
- AKRO 2019
- SKT 1993
- Fundamental
- Price
- AKRO $50.09
- SKT $32.48
- Analyst Decision
- AKRO Strong Buy
- SKT Buy
- Analyst Count
- AKRO 7
- SKT 9
- Target Price
- AKRO $81.57
- SKT $36.44
- AVG Volume (30 Days)
- AKRO 997.3K
- SKT 976.1K
- Earning Date
- AKRO 08-08-2025
- SKT 08-04-2025
- Dividend Yield
- AKRO N/A
- SKT 3.55%
- EPS Growth
- AKRO N/A
- SKT N/A
- EPS
- AKRO N/A
- SKT 0.88
- Revenue
- AKRO N/A
- SKT $561,024,000.00
- Revenue This Year
- AKRO N/A
- SKT $0.94
- Revenue Next Year
- AKRO N/A
- SKT $4.47
- P/E Ratio
- AKRO N/A
- SKT $37.46
- Revenue Growth
- AKRO N/A
- SKT 10.60
- 52 Week Low
- AKRO $21.34
- SKT $27.37
- 52 Week High
- AKRO $58.40
- SKT $37.57
- Technical
- Relative Strength Index (RSI)
- AKRO 49.73
- SKT 57.93
- Support Level
- AKRO $47.10
- SKT $31.44
- Resistance Level
- AKRO $53.02
- SKT $33.10
- Average True Range (ATR)
- AKRO 2.14
- SKT 0.79
- MACD
- AKRO -0.01
- SKT 0.15
- Stochastic Oscillator
- AKRO 51.97
- SKT 83.81
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.